Bouwinvest is pouring an additional $350M into North American CRE over the next two years, led by Bert van den Hoek in its New York office.
Five nine-figure deals closed before the new year, with firms in every asset class keeping their purchases quiet in 2020's closing days.
A confluence of factors, from shrinking lab equipment to digitization to outsourcing, is conspiring to shrink lab space, and change life sciences development.
Looming inflation will drive investors to flock to secure asset classes including life sciences and existing multifamily properties, experts said.
The East Bay is poised for a high growth trajectory over the next several years.
The huge demand for life sciences real estate, including labs and manufacturing, has brought life sciences construction firms a rush of new work.
Flush with cash, European life sciences markets now need to figure how to scale and skill up to match lab space demand.
An analysis of recent fundraising data finds these 11 biotech startups likely in the market for new real estate.
Boston’s King Street Properties made its first Bay Area purchase, making its life sciences real estate portfolio bicoastal.
These were the top deals in Boston during the last week.
We're not asking for your money. This is not a step towards a paywall. Our news is free and we intend to keep it that way.